Found: 12
Select item for more details and to access through your institution.
Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 3, p. 671, doi. 10.4143/crt.2019.387
- By:
- Publication type:
- Article
Impact of Prior Cancer History on the Clinical Outcomes in Advanced Breast Cancer: A Propensity Score--Adjusted, Population-Based Study.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 552, doi. 10.4143/crt.2019.210
- By:
- Publication type:
- Article
Breast Subtypes and Prognosis of Breast Cancer Patients With Initial Bone Metastasis: A Population-Based Study.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.580112
- By:
- Publication type:
- Article
A Novel Prognostic Scoring System Integrating Gene Expressions and Clinicopathological Characteristics to Predict Very Early Relapse in Node-Negative Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01335
- By:
- Publication type:
- Article
Validation of the Prognostic Stage of American Joint Committee on Cancer Eighth Edition Staging Manual in Invasive Lobular Carcinoma Compared to Invasive Ductal Carcinoma and Proposal of a Novel Score System.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.01471
- By:
- Publication type:
- Article
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 7, p. 1877, doi. 10.1007/s00432-019-02930-2
- By:
- Publication type:
- Article
Evaluation of the Incorporation of Recurrence Score into the American Joint Committee on Cancer Eighth Edition Staging System in Patients with T1‐2N0M0, Estrogen Receptor‐Positive, Human Epidermal Growth Receptor 2‐Negative Invasive Breast Cancer: A Population‐Based Analysis
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. e1014, doi. 10.1634/theoncologist.2018-0727
- By:
- Publication type:
- Article
Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 5, p. 400, doi. 10.20892/j.issn.2095-3941.2023.0492
- By:
- Publication type:
- Article
A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.746763
- By:
- Publication type:
- Article
The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.
- Published in:
- Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133221
- By:
- Publication type:
- Article